Cargando…
Inhibition of Ca(2+)-Independent Phospholipase A(2)β (iPLA(2)β) Ameliorates Islet Infiltration and Incidence of Diabetes in NOD Mice
Autoimmune β-cell death leads to type 1 diabetes, and with findings that Ca(2+)-independent phospholipase A(2)β (iPLA(2)β) activation contributes to β-cell death, we assessed the effects of iPLA(2)β inhibition on diabetes development. Administration of FKGK18, a reversible iPLA(2)β inhibitor, to NOD...
Autores principales: | Bone, Robert N., Gai, Ying, Magrioti, Victoria, Kokotou, Maroula G., Ali, Tomader, Lei, Xiaoyong, Tse, Hubert M., Kokotos, George, Ramanadham, Sasanka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303959/ https://www.ncbi.nlm.nih.gov/pubmed/25213337 http://dx.doi.org/10.2337/db14-0097 |
Ejemplares similares
-
Characterization of FKGK18 as Inhibitor of Group VIA Ca(2+)-Independent Phospholipase A(2) (iPLA(2)β): Candidate Drug for Preventing Beta-Cell Apoptosis and Diabetes
por: Ali, Tomader, et al.
Publicado: (2013) -
Genetic modulation of islet β-cell iPLA(2)β expression provides evidence for its impact on β-cell apoptosis and autophagy
por: Lei, Xiaoyong, et al.
Publicado: (2013) -
The Impact of the Ca(2+)-Independent Phospholipase A(2)β (iPLA(2)β) on Immune Cells
por: White, Tayleur D., et al.
Publicado: (2021) -
Alterations in β-Cell Sphingolipid Profile Associated with ER Stress and iPLA(2)β: Another Contributor to β-Cell Apoptosis in Type 1 Diabetes
por: Ali, Tomader, et al.
Publicado: (2021) -
Highly Potent 2-Oxoester Inhibitors of Cytosolic
Phospholipase A(2) (GIVA cPLA(2))
por: Psarra, Anastasia, et al.
Publicado: (2018)